Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus

Christopher McGuigan, Ranjith Pathirana, Marco Migliore, Rina Adak, G Luoni, Arwyn T. Jones, Alberto Diez‐Torrubia, Marı́a-José Camarasa, Sonsoles Velázquez, Geoffrey Henson,

Journal of Antimicrobial Chemotherapy · 2007 · 73 citations · 14 references

Abstract

On the basis of its favourable antiviral and pharmacokinetic properties, FV-100 is now being pursued as the clinical BCNA candidate for the treatment of VZV shingles.

References

14